Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidar Sharafi

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
World Journal of Hepatology|October 13, 2018
Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?Heidar Sharafi, Seyed Moayed Alavian
Jundishapur Journal of Microbiology|May 15, 2015
Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B PatientsMaryam Keshvari, Seyed Moayed Alavian, Heidar Sharafi
Hepatitis Monthly|March 6, 2015
Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1Heidar Sharafi, Seyed Moayed Alavian, Maryam Keshvari
Harm Reduction Journal|January 23, 2021
Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysisAbdolhalim Rajabi, Heidar Sharafi, Seyed Moayed Alavian
International Immunopharmacology|June 25, 2022
Association of single nucleotide polymorphisms in immune-related genes with spontaneous HBsAg seroconversion: A systematic review and meta-analysisHamed Mohammadi, Seyed Moayed Alavian, Heidar Sharafi
Hepatitis Monthly|April 3, 2014
How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level?Maryam Keshvari, Seyed Moayed Alavian, Heidar Sharafi
Virus Research|November 8, 2018
Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBankHeidar Sharafi, Saeideh Maleki, Seyed Moayed Alavian
The Journal of Gene Medicine|December 9, 2017
Association of PNPLA3 rs738409 polymorphism with liver steatosis but not with cirrhosis in patients with HBV infection: Systematic review with meta-analysisSaman Ghalamkari, Heidar Sharafi, Seyed Moayed Alavian
Clinical Chemistry and Laboratory Medicine|September 20, 2018
Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic reviewSeyyed Mortaza Haghgoo, Heidar Sharafi, Seyed Moayed Alavian
Microbial Drug Resistance (Larchmont, N.Y.)|April 26, 2019
Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBankHeidar Sharafi, Saman Ghalamkari, Alireza Hassanshahi, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
World Journal of Hepatology|October 13, 2018
Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?Heidar Sharafi, Seyed Moayed Alavian
Jundishapur Journal of Microbiology|May 15, 2015
Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B PatientsMaryam Keshvari, Seyed Moayed Alavian, Heidar Sharafi
Hepatitis Monthly|March 6, 2015
Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1Heidar Sharafi, Seyed Moayed Alavian, Maryam Keshvari
Harm Reduction Journal|January 23, 2021
Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysisAbdolhalim Rajabi, Heidar Sharafi, Seyed Moayed Alavian
International Immunopharmacology|June 25, 2022
Association of single nucleotide polymorphisms in immune-related genes with spontaneous HBsAg seroconversion: A systematic review and meta-analysisHamed Mohammadi, Seyed Moayed Alavian, Heidar Sharafi
Hepatitis Monthly|April 3, 2014
How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level?Maryam Keshvari, Seyed Moayed Alavian, Heidar Sharafi
Virus Research|November 8, 2018
Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBankHeidar Sharafi, Saeideh Maleki, Seyed Moayed Alavian
The Journal of Gene Medicine|December 9, 2017
Association of PNPLA3 rs738409 polymorphism with liver steatosis but not with cirrhosis in patients with HBV infection: Systematic review with meta-analysisSaman Ghalamkari, Heidar Sharafi, Seyed Moayed Alavian
Clinical Chemistry and Laboratory Medicine|September 20, 2018
Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic reviewSeyyed Mortaza Haghgoo, Heidar Sharafi, Seyed Moayed Alavian
Microbial Drug Resistance (Larchmont, N.Y.)|April 26, 2019
Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBankHeidar Sharafi, Saman Ghalamkari, Alireza Hassanshahi, et al.
Pageof 7